diabetic-retinopathy-detection
Analyzes retinal fundus images to identify and classify stages of diabetic retinopathy using deep learning models trained on extensive retinal imaging datasets. Provides automated detection of microaneurysms, hemorrhages, and exudates characteristic of the disease.
age-related-macular-degeneration-detection
Detects and classifies age-related macular degeneration (AMD) from retinal imaging using specialized AI models. Identifies drusen, geographic atrophy, and neovascular features to stage disease progression.
clinical-decision-support-recommendations
Provides evidence-based recommendations for clinical management based on detected pathologies, disease severity, and patient risk factors. Suggests appropriate follow-up intervals, treatment options, and specialist referrals.
batch-image-processing-and-screening
Processes large volumes of retinal images in batch mode for population-wide screening programs. Enables efficient analysis of hundreds or thousands of images with minimal manual intervention.
model-performance-monitoring-and-validation
Continuously monitors AI model performance in production, comparing predictions against clinician reviews and tracking accuracy metrics. Identifies performance drift and triggers retraining when needed.
automated-retinal-image-quality-assessment
Evaluates the technical quality of retinal images and flags those unsuitable for analysis due to poor focus, inadequate field coverage, or artifacts. Reduces manual review burden by automatically filtering out non-diagnostic images.
patient-data-aggregation-and-management
Centralizes and organizes ophthalmic patient data including imaging, clinical notes, and diagnostic results into a unified patient record. Enables longitudinal tracking of eye health metrics and disease progression across multiple visits.
comparative-imaging-analysis
Automatically compares current retinal images with prior imaging studies to quantify changes in pathology, drusen burden, or other measurable features. Highlights regions of significant change to support disease progression assessment.
+5 more capabilities